Changing factory when you do not have the formula
Your contract manufacturer owns the formula, not you. How reverse analysis lets you move factory anyway, and what a deformulation report cannot tell you.
Changing factory when you do not have the formula
Here is the position most private label brands are in and do not realise until they try to leave.
You paid for development. You paid for samples. You have sold the product for years. Your name is on the box.
You do not have the formula.
The factory has it, they developed it, and in most arrangements it is theirs. Ask for it during a supplier transition and you will get a refusal, a stall, or a version with the important parts missing.
You can still leave. It just costs a lab report.
What is reverse analysis?
Reverse analysis, or deformulation, is laboratory analysis of a finished product to identify its constituent ingredients and approximate their proportions. For a private label brand, it is the mechanism for moving production to a new factory when the incumbent owns the formula and will not release it.
It is legal, routine, and it is what we do when a client needs to leave a supplier who holds their product hostage.
What the report actually gives you
Ingredient identification. What is in the product, named.
Approximate proportions. Enough to rebuild a working formula, not enough to clone the original to the decimal.
Evidence. This is the underrated part. A dated third party report is a document you can put in front of the incumbent, and in front of the new factory, and it settles arguments that would otherwise run for weeks.
What the report cannot tell you
Be clear about this before you spend the money, because a brand expecting a manufacturing recipe will be disappointed.
Process. Order of addition, temperatures, mixing speeds, emulsification method. A cream is as much its process as its ingredients, and none of that survives into the finished product in a readable form.
Raw material grade and origin. Two suppliers of the same INCI name are not interchangeable in feel, colour, or stability.
Anything below detection. Trace actives, some preservative systems, and fragrance components can sit under the threshold.
Whether the formula was good. The report tells you what is in there. It does not tell you it should be.
Which brings us to what we found.
The product that did not contain its own active
We ran reverse analysis on two topical products for a brand moving factory.
One of them was positioned entirely on a sensation effect. That effect was the product. It was the reason the product existed and the reason customers bought it.
The analysis found no verified active responsible for that effect in the formula.
The relationship with that supplier had run eight years.
Nobody had ever checked. There is no reason a brand would check, because the product sold, the reviews were fine, and the label said what it always said.
This is the argument for running reverse analysis even when you are not changing supplier. You are not only buying a formula. You are buying the first independent look at what you have been selling.
Turning the report into something a factory can quote
A deformulation report is not a manufacturing brief. Converting it takes three steps.
- Screen out what should not be there.
Reverse analysis frequently surfaces ingredients that are restricted in your target markets, or that you simply do not want on a modern label. In this case we removed a nonylphenol ethoxylate surfactant, which is prohibited in EU cosmetics, along with parabens and triethanolamine.
Screen against the markets you sell into, not the market the product was made in.
- Rebuild it as a phase-by-phase formula.
Aqueous phase, oil phase, cool-down phase, with each ingredient placed, at percentage. This is the format a factory R&D team can actually quote and produce against. A flat ingredient list is not.
- Turn the open questions into decisions, in writing.
A rebuild always leaves choices: which sensate profile, how much humectant, what fill size, what pack format. Put them in the specification as explicitly open, with the options named. Undecided and documented is a professional position. Undecided and silent is how a factory decides for you.
Why you cannot get a real bulk price yet
Brands ask for unit price, lead time and payment terms at this stage. It is the natural question and it cannot be answered honestly yet.
The production formula is not final until a factory is selected and a sample is approved, and the formula is what determines the cost. Any bulk number quoted before that is a placeholder that will move.
The correct sequence: brief, factory shortlist, sample, approval, then price.
A supplier who quotes firm bulk pricing against a formula nobody has produced yet is quoting a number they intend to revise.
Key facts
- In most private label arrangements the contract manufacturer owns the formula, not the brand.
- Reverse analysis identifies ingredients and approximate proportions from a finished product.
- It cannot recover process, raw material grade, or components below detection.
- A dated third party analysis report is evidence, usable with both the incumbent and the new factory.
- Reverse analysis can reveal that a product does not contain the active its positioning depends on.
- Rebuilt formulas must be screened against the regulations of the markets you sell into.
- Honest bulk pricing comes after sample approval, because the approved formula determines the cost.
Moving a product to a new factory?
We are based in Shanghai. We commission the analysis, rebuild the formula, and run the factory search.
Contact us via E-mail or WhatsApp.
Hamza runs Kuai Sourcing from Shanghai. Member of the China Electronics Chamber of Commerce (CECC).
